EXPLANATION – Matter in bolded italics is new; matter between brackets [omitted material] is material to be omitted. Green numbers along left margin indicate location on the printed bill (e.g., 5-15 indicates page 5, line 15).

1-1 Whereas, Chronic fatigue syndrome is an illness characterized by

1-2 prolonged, debilitating fatigue and multiple symptoms such as headaches,

1-3 muscle and joint pains, sleep disturbances, recurrent sore throats and

1-4 cognitive impairment; and

1-5 Whereas, This illness is often misdiagnosed and its cause erroneously

1-6 attributed to irrelevant conditions; and

1-7 Whereas, Because the cause of this illness is unknown and there are no

1-8 diagnostic tests, this illness is diagnosed when the symptoms persist for

1-9 more than 6 months and cannot be attributed to any other medical

1-10 condition; and

1-11 Whereas, Recent studies have indicated that chronic fatigue syndrome

1-12 is a far greater public health problem than previously known, affecting men

1-13 and women of all racial and ethnic groups, as well as adolescents, with the

1-14 highest prevalence occurring among Caucasian women; and

1-15 Whereas, Many patients with chronic fatigue syndrome are unable to

1-16 continue holding jobs, attending school or caring for family members; and

1-17 Whereas, Treatment of chronic fatigue syndrome is currently focused

1-18 on symptomatic relief since there is no single drug or group of drugs

1-19 specific to this disease; and

2-1 Whereas, Extensive scientific research is needed to determine the

2-2 cause and cure for chronic fatigue syndrome, such as the recent

2-3 double-blind, placebo-controlled, crossover pilot study conducted at

2-4 Georgetown University Medical Center resulting in the discovery that a

2-5 naturally occurring coenzyme, commercially available as ENADAâ , can

2-6 alleviate symptoms of this debilitating illness; and

2-7 Whereas, Nevada’s own Dr. Daniel L. Peterson, who is a member of

2-8 the Sierra Internal Medicine Associates in Incline Village, Nevada, is well

2-9 known for his role in the fight against chronic fatigue syndrome; and

2-10 Whereas, Since 1984, Dr. Peterson has treated more than 2,000

2-11 patients with chronic fatigue syndrome; and

2-12 Whereas, Dr. Peterson’s dedication to this cause is evidenced by his

2-13 tenure as Medical Director of the Fatigue Clinic for the diagnosis of fatigue

2-14 and the treatment of chronic fatigue and immune dysfunction syndrome at

2-15 the Neurology Clinic of the University of California, San Francisco; and

2-16 Whereas, Dr. Peterson is a member of the International Chronic

2-17 Fatigue Syndrome Study Group, and has earned nationwide recognition as

2-18 co-author of many articles relating to chronic fatigue syndrome which have

2-19 appeared in medical journals and publications throughout the country; and

2-20 Whereas, In treating patients with chronic fatigue syndrome, Dr.

2-21 Peterson has drawn on practices that have made medicine a valued art by

2-22 ruling out alternative problems, ameliorating symptoms, using alternative

2-23 treatments and offering guidance with compassion; now, therefore, be it

2-24 Resolved by the Assembly and Senate of the State of Nevada,

2-25 Jointly, That the members of the 70th session of the Nevada Legislature

2-26 do hereby commend Dr. Peterson for his outstanding work and selfless

2-27 dedication on behalf of persons with chronic fatigue syndrome; and be it

2-28 further

2-29 Resolved, That the Nevada Legislature hereby urges Congress to

2-30 provide financial support and ensure that federal health agencies allocate

2-31 increasing resources for additional scientific research to combat chronic

2-32 fatigue syndrome; and be it further

2-33 Resolved, That the Chief Clerk of the Assembly prepare and transmit a

2-34 copy of this resolution to Dr. Daniel L. Peterson and to the Vice President

2-35 of the United States as the presiding officer of the Senate, the Speaker of

2-36 the House of Representatives and each member of the Nevada

2-37 Congressional Delegation; and be it further

2-38 Resolved, That this resolution becomes effective upon passage and

2-39 approval.